TY - JOUR
AU - K Mahaffey
BT - Circulation
PY - 2020
SP - 407 
EP -  410
T2 - Circulation
TI - Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial
VL - 141
ER -